F943-0117 Screening compound: 3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-6-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)sulfonyl]-2,3-dihydro-1,3-benzothiazol-2-one

F943-0117 Screening compound: 3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-6-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)sulfonyl]-2,3-dihydro-1,3-benzothiazol-2-one
F943-0117 Screening compound: 3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-6-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)sulfonyl]-2,3-dihydro-1,3-benzothiazol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F943-0117
3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-6-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)sulfonyl]-2,3-dihydro-1,3-benzothiazol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F943-0117

Molecular Formula

C24H25N3O4S2 (C24 H25 N3 O4 S2)

Compound Name

3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-6-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)sulfonyl]-2,3-dihydro-1,3-benzothiazol-2-one

IUPAC name

3-[2-oxo-2-(pyrrolidin-1-yl)ethyl]-6-[(4-phenyl-1236-tetrahydropyridin-1-yl)sulfonyl]-23-dihydro-13-benzothiazol-2-one

SMILES

O=C(CN(c(ccc(S(N(CC1)CC=C1c1ccccc1)(=O)=O)c1)c1S1)C1=O)N1CCCC1

InChI

InChI=1S/C24H25N3O4S2/c28-23(25-12-4-5-13-25)17-27-21-9-8-20(16-22(21)32-24(27)29)33(30,31)26-14-10-19(11-15-26)18-6-2-1-3-7-18/h1-3,6-10,16H,4-5,11-15,17H2

InChI Key

PKMNECIMKWJVNH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27205186

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.127

Distribution Coefficient, logD

4.127

Water Solubility, LogSw

-4.25

Polar Surface Area

64.009

Acid Dissociation Constant (pKa)

21.85

Base Dissociation Constant (pKb)

-0.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

F943-0117 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F943-0117 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F943-0117?
Check Price and Availability of F943-0117, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F943-0117 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F943-0117
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F943-0117
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F943-0117 available by request